A trial of automated decision support alerts for contraindicated medications using computerized physician order entry

William L Galanter1, Robert J Didomenico, Audrius Polikaitis

  • 1University of Illinois at Chicago, Department of Medicine, Section of General Internal Medicine (M/C 718), 840 S. Wood St, Chicago, IL 60612, USA. billg@uic.edu

Abstract

Insights

Automated clinical decision support alerts effectively reduced contraindicated medication administration in patients with renal insufficiency. Alert compliance improved with housestaff training and in male patients with worsening renal function.

Area of Science:

  • Clinical Informatics
  • Nephrology
  • Pharmacology

Background:

  • Automated clinical decision support (CDS) systems show potential for reducing medication errors.
  • Clinician non-adherence to CDS alerts remains a significant challenge.
  • Medication errors frequently arise from renal insufficiency, necessitating targeted interventions.

Purpose of the Study:

  • To evaluate the effectiveness of a novel alert system designed to prevent the inpatient administration of medications contraindicated in patients with renal insufficiency.
  • To identify factors influencing clinician compliance with these specific alerts.

Main Methods:

  • Established minimum safe creatinine clearance thresholds for inpatient medications.
  • Implemented alerts triggered by medication orders for patients with creatinine clearance below established thresholds.
  • Analyzed medication administration data pre- and post-alert implementation (4 months pre, 14 months post).
  • Examined the impact of patient demographics, renal function severity, and housestaff training duration on alert compliance.

Main Results:

  • Significant reduction in the administration of contraindicated drugs, from 89% to 47% (p < 0.0001) post-alert implementation.
  • Alert compliance was higher in male patients (57% vs. 38%, p = 0.02).
  • Compliance increased with longer housestaff training duration (p = 0.04) and in patients with more severe renal dysfunction (p = 0.007).

Conclusions:

  • The implemented alerts were effective in reducing the ordering and administration of drugs contraindicated due to renal insufficiency.
  • Factors such as patient gender, duration of housestaff training, and degree of renal dysfunction influenced alert compliance.

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.